We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dr. Reddy's Generic Infringes Aloxi Patents, Judge Rules

Law360, Los Angeles (February 15, 2017, 10:46 PM EST) -- A New Jersey federal judge on Wednesday found that Dr. Reddy’s Laboratories Inc.’s planned generic version of Helsinn Healthcare SA’s anti-nausea drug Aloxi infringes three patents for the drug and rejected...
To view the full article, register now.